Jefferies Group’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-44,000
Closed -$1.41M 1777
2021
Q4
$1.41M Buy
44,000
+28,000
+175% +$1.02M 0.01% 900
2021
Q3
$576K Buy
+16,000
New +$630K ﹤0.01% 1177

Other funds holding LUNG

Jefferies Group's LUNG Position: Q3 2022 in Review

Jefferies Group increased its Pulmonx (LUNG) stake by 34% in Q3 2022, buying an estimated $5.65M and bringing the position to 1,201,553 shares worth $20M. The position accounts for 0.17% of the portfolio, ranked #95.

Jefferies Group first reported a position in LUNG in Q4 2021 and has held it in 3 quarters since. 104 funds tracked by Wall St. Rank hold LUNG as of Q3 2022.

  • Jefferies Group held 1,201,553 shares of Pulmonx worth $20M as of Q3 2022.
  • Jefferies Group bought 306,643 Pulmonx shares in Q3 2022, an estimated $5.65M.
  • Pulmonx made up 0.17% of Jefferies Group's portfolio in Q3 2022, its #95 holding.
  • Jefferies Group first reported a position in Pulmonx in Q4 2021 and has held it in 3 quarters since.
  • 104 funds tracked by Wall St. Rank held Pulmonx as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.